• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
A high affinity interaction of plasminogen with fibrin is not essential for efficient activation by tissue-type plasminogen activator.纤溶酶原与纤维蛋白的高亲和力相互作用对于组织型纤溶酶原激活物的有效激活并非必需。
J Biol Chem. 2012 Feb 10;287(7):4652-61. doi: 10.1074/jbc.M111.317719. Epub 2011 Dec 20.
2
Regulation of nonproteolytic active site formation in plasminogen.纤溶酶原中非蛋白水解活性位点形成的调控。
Biochemistry. 2007 Jul 31;46(30):8879-87. doi: 10.1021/bi602591g. Epub 2007 Jul 7.
3
Characterization of the interactions of plasminogen and tissue and vampire bat plasminogen activators with fibrinogen, fibrin, and the complex of D-dimer noncovalently linked to fragment E.纤溶酶原、组织型和吸血蝙蝠纤溶酶原激活剂与纤维蛋白原、纤维蛋白以及与E片段非共价连接的D-二聚体复合物之间相互作用的表征
J Biol Chem. 1998 Jul 17;273(29):18292-9. doi: 10.1074/jbc.273.29.18292.
4
Reduced plasminogen binding and delayed activation render γ'-fibrin more resistant to lysis than γA-fibrin.纤溶酶原结合减少和激活延迟使γ'-纤维蛋白比γA-纤维蛋白对溶解更具抗性。
J Biol Chem. 2014 Oct 3;289(40):27494-503. doi: 10.1074/jbc.M114.588640. Epub 2014 Aug 15.
5
Epsilon amino caproic acid inhibits streptokinase-plasminogen activator complex formation and substrate binding through kringle-dependent mechanisms.ε-氨基己酸通过kringle依赖性机制抑制链激酶-纤溶酶原激活物复合物的形成和底物结合。
Biochemistry. 2000 Apr 25;39(16):4740-5. doi: 10.1021/bi992028x.
6
Mechanism of plasmin generation by S100A10.S100A10 生成纤溶酶的机制。
Thromb Haemost. 2017 Jun 2;117(6):1058-1071. doi: 10.1160/TH16-12-0936. Epub 2017 Apr 6.
7
Kinetics of activated thrombin-activatable fibrinolysis inhibitor (TAFIa)-catalyzed cleavage of C-terminal lysine residues of fibrin degradation products and removal of plasminogen-binding sites.活化凝血酶激活纤溶抑制物(TAFIa)催化纤维蛋白降解产物 C 末端赖氨酸残基裂解及去除纤溶酶原结合位点的动力学。
J Biol Chem. 2011 Jun 3;286(22):19280-6. doi: 10.1074/jbc.M110.215061. Epub 2011 Apr 5.
8
A steady-state template model that describes the kinetics of fibrin-stimulated [Glu1]- and [Lys78]plasminogen activation by native tissue-type plasminogen activator and variants that lack either the finger or kringle-2 domain.一种稳态模板模型,该模型描述了天然组织型纤溶酶原激活剂以及缺乏指状结构域或kringle-2结构域的变体对纤维蛋白刺激的[Glu1]-和[Lys78]纤溶酶原激活的动力学。
J Biol Chem. 1997 Jan 24;272(4):2183-91. doi: 10.1074/jbc.272.4.2183.
9
Identification and characterization of novel tPA- and plasminogen-binding sites within fibrin(ogen) alpha C-domains.纤维蛋白(原)α C 结构域内新型组织型纤溶酶原激活剂(tPA)和纤溶酶原结合位点的鉴定与表征
Biochemistry. 2001 Jan 23;40(3):801-8. doi: 10.1021/bi001789t.
10
[The effect of kringles K1-3, K4 and K5 on lysis of fibrin clots caused by the activation of Glu- and Lys-plasminogen by a tissue activator].[kringle K1 - 3、K4和K5对组织激活剂激活谷氨酸纤溶酶原和赖氨酸纤溶酶原所引起的纤维蛋白凝块溶解的影响]
Ukr Biokhim Zh (1978). 1989 Jul-Aug;61(4):31-6.

引用本文的文献

1
Clot formation, structure, and fibrinolysis of plasma from pancreatic cancer patients.胰腺癌患者血浆的凝血形成、结构及纤维蛋白溶解
J Thromb Thrombolysis. 2025 Jul 14. doi: 10.1007/s11239-025-03118-x.
2
Protofibril packing density of individual fibers alters fibrinolysis.单个纤维的原纤维堆积密度会改变纤维蛋白溶解。
Res Pract Thromb Haemost. 2025 Feb 28;9(2):102708. doi: 10.1016/j.rpth.2025.102708. eCollection 2025 Feb.
3
Clot formation, structure, and fibrinolysis of pancreatic cancer patients.胰腺癌患者的血栓形成、结构及纤维蛋白溶解
Res Sq. 2025 Feb 11:rs.3.rs-5868575. doi: 10.21203/rs.3.rs-5868575/v1.
4
Unravelling the impact of SARS-CoV-2 on hemostatic and complement systems: a systems immunology perspective.从系统免疫学角度解析严重急性呼吸综合征冠状病毒2(SARS-CoV-2)对止血和补体系统的影响
Front Immunol. 2025 Jan 13;15:1457324. doi: 10.3389/fimmu.2024.1457324. eCollection 2024.
5
Freeze-dried plasma: Hemostasis and biophysical analyses for damage control resuscitation.冻干血浆:用于损伤控制复苏的止血及生物物理分析
Transfusion. 2025 May;65 Suppl 1(Suppl 1):S250-S264. doi: 10.1111/trf.18124. Epub 2025 Jan 13.
6
Optimization of plasma-based BioID identifies plasminogen as a ligand of ADAMTS13.基于等离子体的 BioID 的优化将纤溶酶原鉴定为 ADAMTS13 的配体。
Sci Rep. 2024 Apr 20;14(1):9073. doi: 10.1038/s41598-024-59672-6.
7
Tissue-type plasminogen activator (tPA) homozygous Tyr471His mutation associates with thromboembolic disease.组织型纤溶酶原激活剂(tPA)纯合子Tyr471His突变与血栓栓塞性疾病相关。
MedComm (2020). 2023 Oct 5;4(5):e392. doi: 10.1002/mco2.392. eCollection 2023 Oct.
8
Thrombus composition and thrombolysis resistance in stroke.中风中的血栓成分与溶栓抵抗
Res Pract Thromb Haemost. 2023 May 16;7(4):100178. doi: 10.1016/j.rpth.2023.100178. eCollection 2023 May.
9
Fibrinolysis: an illustrated review.纤维蛋白溶解:图文并茂的综述。
Res Pract Thromb Haemost. 2023 Feb 17;7(2):100081. doi: 10.1016/j.rpth.2023.100081. eCollection 2023 Feb.
10
Assays to quantify fibrinolysis: strengths and limitations. Communication from the International Society on Thrombosis and Haemostasis Scientific and Standardization Committee on fibrinolysis.定量纤溶的检测方法:优缺点。国际血栓与止血学会科学和标准化委员会关于纤溶的通讯。
J Thromb Haemost. 2023 Apr;21(4):1043-1054. doi: 10.1016/j.jtha.2023.01.008. Epub 2023 Jan 14.

本文引用的文献

1
Histidine-rich glycoprotein binds fibrin(ogen) with high affinity and competes with thrombin for binding to the gamma'-chain.组氨酸丰富糖蛋白以高亲和力结合纤维蛋白(原),并与凝血酶竞争与γ'-链结合。
J Biol Chem. 2011 Sep 2;286(35):30314-30323. doi: 10.1074/jbc.M111.253831. Epub 2011 Jul 8.
2
Bivalent binding to gammaA/gamma'-fibrin engages both exosites of thrombin and protects it from inhibition by the antithrombin-heparin complex.与γA/γ'-纤维蛋白的二价结合可使凝血酶的两个外位点都参与其中,并保护其免受抗凝血酶-肝素复合物的抑制。
J Biol Chem. 2008 Feb 1;283(5):2470-7. doi: 10.1074/jbc.M707710200. Epub 2007 Nov 30.
3
Isolation and characterization of cotiaractivase, a novel low molecular weight prothrombin activator from the venom of Bothrops cotiara.从柯氏矛头蝮蛇毒中分离并鉴定一种新型低分子量凝血酶原激活剂——柯氏激活酶。
Biochim Biophys Acta. 2006 May;1764(5):863-71. doi: 10.1016/j.bbapap.2006.03.004. Epub 2006 Apr 7.
4
Synthetic peptide F2A4-K-NS mimics fibroblast growth factor-2 in vitro and is angiogenic in vivo.合成肽F2A4-K-NS在体外模拟成纤维细胞生长因子-2,在体内具有血管生成作用。
Int J Mol Med. 2006 May;17(5):833-9. doi: 10.3892/ijmm.17.5.833.
5
A study of the protection of plasmin from antiplasmin inhibition within an intact fibrin clot during the course of clot lysis.一项关于在血凝块溶解过程中完整纤维蛋白凝块内纤溶酶免受抗纤溶酶抑制的保护作用的研究。
J Biol Chem. 2004 Apr 2;279(14):13333-9. doi: 10.1074/jbc.M313164200. Epub 2004 Jan 8.
6
The fibrinolysis system: regulation of activity and physiologic functions of its main components.纤维蛋白溶解系统:其主要成分的活性调节及生理功能
Biochemistry (Mosc). 2002 Jan;67(1):99-108. doi: 10.1023/a:1013960416302.
7
Elements of the fibrinolytic system.纤维蛋白溶解系统的组成部分。
Ann N Y Acad Sci. 2001;936:226-36. doi: 10.1111/j.1749-6632.2001.tb03511.x.
8
The molecular weights, mass distribution, chain composition, and structure of soluble fibrin degradation products released from a fibrin clot perfused with plasmin.用纤溶酶灌注纤维蛋白凝块释放出的可溶性纤维蛋白降解产物的分子量、质量分布、链组成和结构。
J Biol Chem. 1999 Feb 19;274(8):5201-12. doi: 10.1074/jbc.274.8.5201.
9
Characterization of the interactions of plasminogen and tissue and vampire bat plasminogen activators with fibrinogen, fibrin, and the complex of D-dimer noncovalently linked to fragment E.纤溶酶原、组织型和吸血蝙蝠纤溶酶原激活剂与纤维蛋白原、纤维蛋白以及与E片段非共价连接的D-二聚体复合物之间相互作用的表征
J Biol Chem. 1998 Jul 17;273(29):18292-9. doi: 10.1074/jbc.273.29.18292.
10
Fibrinolysis with des-kringle derivatives of plasmin and its modulation by plasma protease inhibitors.纤溶酶去kringle结构域衍生物的纤维蛋白溶解作用及其受血浆蛋白酶抑制剂的调节
Biochemistry. 1998 Jun 23;37(25):9112-8. doi: 10.1021/bi980180d.

纤溶酶原与纤维蛋白的高亲和力相互作用对于组织型纤溶酶原激活物的有效激活并非必需。

A high affinity interaction of plasminogen with fibrin is not essential for efficient activation by tissue-type plasminogen activator.

机构信息

Departments of Medicine and Biochemistry and Biomedical Sciences, McMaster University and Thrombosis and Atherosclerosis Research Institute, Hamilton, Ontario L8L 2X2, Canada.

出版信息

J Biol Chem. 2012 Feb 10;287(7):4652-61. doi: 10.1074/jbc.M111.317719. Epub 2011 Dec 20.

DOI:10.1074/jbc.M111.317719
PMID:22187433
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3281636/
Abstract

Fibrin (Fn) enhances plasminogen (Pg) activation by tissue-type plasminogen activator (tPA) by serving as a template onto which Pg and tPA assemble. To explore the contribution of the Pg/Fn interaction to Fn cofactor activity, Pg variants were generated and their affinities for Fn were determined using surface plasmon resonance (SPR). Glu-Pg, Lys-Pg (des(1-77)), and Mini-Pg (lacking kringles 1-4) bound Fn with K(d) values of 3.1, 0.21, and 24.5 μm, respectively, whereas Micro-Pg (lacking all kringles) did not bind. The kinetics of activation of the Pg variants by tPA were then examined in the absence or presence of Fn. Whereas Fn had no effect on Micro-Pg activation, the catalytic efficiencies of Glu-Pg, Lys-Pg, and Mini-Pg activation in the presence of Fn were 300- to 600-fold higher than in its absence. The retention of Fn cofactor activity with Mini-Pg, which has low affinity for Fn, suggests that Mini-Pg binds the tPA-Fn complex more tightly than tPA alone. To explore this possibility, SPR was used to examine the interaction of Mini-Pg with Fn in the absence or presence of tPA. There was 50% more Mini-Pg binding to Fn in the presence of tPA than in its absence, suggesting that formation of the tPA-Fn complex exposes a cryptic site that binds Mini-Pg. Thus, our data (a) indicate that high affinity binding of Pg to Fn is not essential for Fn cofactor activity, and (b) suggest that kringle 5 localizes and stabilizes Pg within the tPA-Fn complex and contributes to its efficient activation.

摘要

纤维蛋白(Fn)作为纤维蛋白原(Pg)和组织型纤溶酶原激活物(tPA)组装的模板,增强 tPA 对纤溶酶原的激活。为了探究 Pg/Fn 相互作用对 Fn 辅因子活性的贡献,生成了 Pg 变体,并使用表面等离子体共振(SPR)测定了它们与 Fn 的亲和力。Glu-Pg、Lys-Pg(des(1-77))和 Mini-Pg(缺乏环 1-4)与 Fn 的 K(d)值分别为 3.1、0.21 和 24.5 μm,而 Micro-Pg(缺乏所有环)则不结合 Fn。然后在不存在或存在 Fn 的情况下,研究了 Pg 变体被 tPA 激活的动力学。尽管 Fn 对 Micro-Pg 激活没有影响,但在 Fn 存在的情况下,Glu-Pg、Lys-Pg 和 Mini-Pg 的催化效率比不存在 Fn 时高 300-600 倍。Mini-Pg 保留了 Fn 辅因子活性,尽管它与 Fn 的亲和力较低,但这表明 Mini-Pg 与 tPA-Fn 复合物的结合比 tPA 单独结合更紧密。为了探究这种可能性,使用 SPR 研究了 Mini-Pg 在不存在或存在 tPA 的情况下与 Fn 的相互作用。在存在 tPA 的情况下,Mini-Pg 与 Fn 的结合增加了 50%,这表明 tPA-Fn 复合物的形成暴露了一个结合 Mini-Pg 的隐蔽位点。因此,我们的数据表明:(a)Pg 与 Fn 的高亲和力结合对于 Fn 辅因子活性不是必需的;(b)kringle 5 定位并稳定 Pg 位于 tPA-Fn 复合物内,并有助于其有效的激活。